Search Results 141-150 of 16085 for hla genotype
... genotype associated ADRs which are causally related to the initial drug of inclusion (referred to as 'index drug'). Participation eligibility. Participant ...
donor, or HLA 1-antigen mismatched unrelated donor, with either bone marrow or peripheral blood stem cells as a graft source, and with any conditioning ...
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182 ...
... genotype-phenotype relationships. Located in Rochester, Minnesota, and led by principal investigator Michael J. Ackerman, M.D., Ph.D., the Sudden Death ...
have the ability to do very high-quality genotyping, that is, these markers across the genome so we can find genes. And just here at Mayo we have four ...
... genotype and phenotype information collected during routine clinical care. We will also utilize the database to improve reporting of clinical test results ...
Griffiths' lab team has developed novel technologies for high-throughput immunoproteomic identification of HLA , non- HLA and nonprotein (for example ...
The Sponsor will review the results of HLA typing for inclusion alleles, and will adjudicate subject eligibility based on HLA results. ... Positive for any HLA-A* ...
Donor/recipient HLA matching: Related donor ... Unrelated donor: must be a 7/8 or 8/8 match at HLA ... genotype). The results should be included as part ...
The purpose of this study is to define and genotype the immunomodulatory properties of mesenchymal stem cells (MSCs) from Crohn's disease subjects as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.